[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651690":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":39,"responsibleParty":56,"collaborators":58,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":41,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":41,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":83,"whyStopped":41,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Diabetes Foundation, India","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","ACTIVE_COMPARATOR","CSIR-Developed High-Protein, Low-Glycaemic Index Rice",[13],"Dietary Supplement: Intervention Group",{"label":15,"type":10,"description":16,"interventionNames":17},"Control Group","Conventional Rice",[13],[19],{"type":20,"name":9,"description":21,"armGroupLabels":22,"otherNames":23},"DIETARY_SUPPLEMENT","High-Protein, Low-Glycaemic Index Rice",[15,9],[11],[25],{"name":26,"affiliation":27,"role":28},"Anoop Misra, M.D.","National Diabetes, Obesity and Cholesterol Foundation (N-DOC)","PRINCIPAL_INVESTIGATOR",[30,35],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","011-41759672","103","anoopmisra@gmail.com",{"name":36,"role":31,"phone":32,"phoneExt":37,"email":38},"Seema Gulati, Ph.d","102","seemagulati2007@gmail.com",[40],{"facility":27,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},null,"New Delhi","National Capital Territory of Delhi","110016","India","IN",{"type":48,"coordinates":49},"Point",[50,51],77.2148,28.62137,{"lat":51,"lon":50},[54],{"name":41,"role":31,"phone":55,"phoneExt":41,"email":41},"01141759672",{"type":57,"investigatorFullName":41,"investigatorTitle":41,"investigatorAffiliation":41,"oldNameTitle":41,"oldOrganization":41},"SPONSOR",[59,61],{"name":27,"class":60},"UNKNOWN",{"name":62,"class":60},"CSIR National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram","100651690","effect-of-csir-developed-high-protein-low-glycaemic-index-rice-on-glycaemic-response-in-individuals-with-prediabetes-100651690",false,"NCT07762768","Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With Prediabetes","Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With Prediabetes: An Acute and Subacute Crossover Study","Inclusion Criteria:\n\n* Age 18-60 years\n* Individuals with prediabetes, defined by oral glucose tolerance test (OGTT) as:\n\n  * Fasting plasma glucose ≥100 mg\u002FdL and \\\u003C126 mg\u002FdL, and\u002For\n  * 2-hour plasma glucose ≥140 mg\u002FdL and \\\u003C200 mg\u002FdL following ingestion of 75 g anhydrous glucose\n* Willingness to participate and comply with study procedures\n\nExclusion Criteria:\n\n* Diagnosed diabetes mellitus\n* Acute infections or any debilitating illness\n* History of hepatic, pancreatic, renal, or cardiovascular disease\n* Abnormal liver or renal function tests\n* Recent (\\\u003C3 months) weight change ≥5% or use of weight-altering medications\n* Use of glucose-lowering medications\n* Pregnancy or lactation\n* Known allergy or intolerance to study foods\n* Any condition that, in the investigator's opinion, may interfere with study participation","ALL","18 Years","60 Years",{"count":74,"type":75},36,"ESTIMATED","INTERVENTIONAL",[78],"NA","This is a randomized, controlled, two-phase crossover study will be conducted in adults aged 18-60 years with prediabetes to compare the effects of a CSIR-developed high-protein, low-glycaemic index rice with conventional rice. Phase I will evaluate acute postprandial glucose, insulin, C-peptide, GLP-1, and hunger\u002Fsatiety responses, while Phase II will assess 72-hour continuous glucose monitoring (CGM) outcomes, including mean glucose and glycaemic variability. Eligible participants will be randomly assigned to receive both rice types in a crossover manner, with each participant serving as their own control. Individuals with diabetes, major systemic illnesses, abnormal liver or renal function, pregnancy, or glucose-lowering medication use will be excluded.",[81],"Prediabetes",[21,16,81],"NOT_YET_RECRUITING","2026-08-11",{"date":86,"type":87},"2026-08-13","ACTUAL",{"date":89,"type":75},"2026-09-01",{"date":91,"type":75},"2027-02-28",{"name":5,"class":6},1]